Heron Therapeutics Inc (NASDAQ:HRTX)

Delayed Data
As of 3:59pm ET
 -0.055 / -3.67%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median estimate represents a +280.62% increase from the last price of 1.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.92%
Growthannually 47.31%


Growthquarterly 16.05%
Growthannually 20.89%
Key to the earnings and sales forecast charts.